Ki Y Chung MD
Breast Cancer, Gastrointestinal Cancer, Hematologic Oncology
Associate professor of medicine, MD
Join to view full profile
120 Dillon DrSpartanburg, SC 29307
Phone+1 864-699-5700
Fax+1 864-699-5701
Dr. Chung is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1999 - 2003
Johns Hopkins UniversityResidency, Internal Medicine, 1995 - 1999
University of North Carolina at Chapel Hill School of MedicineClass of 1995
Certifications & Licensure
SC State Medical License 2011 - 2027
NY State Medical License 1999 - 2013
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2017
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2013-2017
- CMS Meaningful Use Stage 1 Certification MOSAIQ, Elekta - IMPAC Medical Systems, Inc., 2013-2017
Clinical Trials
- Study of Imprime PGG® in Combination With Cetuximab in Subjects With Recurrent or Progressive KRAS Wild Type Colorectal Cancer
- Avelumab in Third-Line Gastric Cancer (JAVELIN Gastric 300) Start of enrollment: 2015 Dec 28
- Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Non Hodgkin Lymphoma (B-NHL)
Publications & Presentations
PubMed
- Utility of Circulating Tumor DNA to Assess Tumor Response in Patients with Locally Advanced Rectal Cancer Undergoing Neoadjuvant Therapy.Sakti Chakrabarti, Stacey A Cohen, Antony Tin, Autumn Dangl, Ki Y Chung
Cancers. 2026-02-11 - Metabolic Signatures of Breast Cancer Subtypes and the Metabolic Impact of Chemotherapy.Aubrey Mattingly, Zoe Vickery, Alex Fiorentino, Ethan Wilson, Sydney McCune
Metabolites. 2026-01-08 - 6 citationsFirst-in-human phase I study of EMB-02, a bispecific antibody targeting PD-1 and LAG-3 in patients with advanced solid tumors.Daphne Day, Vinod Ganju, Ki Chung, Lu Si, Lili Mao
British Journal of Cancer. 2025-06-01
Press Mentions
How This New Device Helped Save Patient with Stage Four Rectal CancerJune 8th, 2026
Grant Support
- NCORP of the Carolinas (Greenville Health System NCORP)PRISMA HEALTH - UPSTATE2025–2026
- NCORP of the Carolinas (Greenville Health System NCORP)PRISMA HEALTH - UPSTATE2025–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
